Lowering Drug Prices by Once Again Putting Americans First

President Donald Trump issued Executive Order 14273 on April 15, 2025, aiming to reduce prescription drug prices in the U.S. by enhancing transparency, competition, and value in the pharmaceutical industry. The order directs various government agencies to improve Medicare drug price negotiations, stabilize Medicare Part D premiums, and ensure the availability of affordable life-saving medications like insulin. This action could face legal and political challenges, particularly concerning the balance between reducing drug costs and maintaining pharmaceutical innovation.